Lilly Posts Q2 Loss on Zyprexa Settlement

... Newsroom - Inside INdiana Business with Gerry Dick /*IE and NN6x styles*/ Terre Haute Paper Mill Faces Closure or Sale .PollBox { text-align: left; background-color: #666; margin-left: 10px; margin-bottom: 5px; padding: 4px; border: 1px solid #FFF; } #WeeklyPoll { } #WeeklyPoll p { margin: 0; color: #FFF; font-weight: bold; } #WeeklyPollError { background-color: #FFF; display: none; } #WeeklyPollError p { margin: 0; color: #FFF; font-weight: bold; } #WeeklyPollSuccess { display: none; } #WeeklyPollSuccess p { margin: 0; color: #FFF; font-weight: bold; } You need to select Yes or No for your Poll Answer!

Do lists, like Money Magazine's "Best Places to Live," help attract jobs and investment?

Yes No Your vote was recorded successfully.

Be sure to tune in to this week's show to hear the results.

h4 { font: 13px arial, verdana, helvetica, tahoma, sans serif; font-weight: bold; margin: 0; color: #000; } p { font: 12px; color: #000; } Lilly Posts Q2 Loss on Zyprexa Settlement InsideINdianaBusiness.com Report 7/21/2005 7:30:07 AM Eli Lilly and Co.

(NYSE:LLY) is this morning reporting a second quarter loss of $252 million, or $0.23 per share.

The company blames the loss on a recent charge to settle a product liability case for its anti-psychotic drug Zyprexa.

Excluding the charges, Lilly posted earnings of $728 million, which is...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news